NO742419L - - Google Patents
Info
- Publication number
- NO742419L NO742419L NO742419A NO742419A NO742419L NO 742419 L NO742419 L NO 742419L NO 742419 A NO742419 A NO 742419A NO 742419 A NO742419 A NO 742419A NO 742419 L NO742419 L NO 742419L
- Authority
- NO
- Norway
- Prior art keywords
- paper
- cellulose paper
- test strip
- absorbent material
- group
- Prior art date
Links
- 239000000463 material Substances 0.000 claims description 53
- 239000002250 absorbent Substances 0.000 claims description 43
- 230000002745 absorbent Effects 0.000 claims description 43
- 229920002678 cellulose Polymers 0.000 claims description 31
- 239000001913 cellulose Substances 0.000 claims description 31
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 19
- 239000008103 glucose Substances 0.000 claims description 19
- 229930182830 galactose Natural products 0.000 claims description 18
- 210000002700 urine Anatomy 0.000 claims description 18
- 238000001514 detection method Methods 0.000 claims description 14
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 13
- 238000005342 ion exchange Methods 0.000 claims description 13
- 102000003992 Peroxidases Human genes 0.000 claims description 12
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 12
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 12
- 239000000758 substrate Substances 0.000 claims description 12
- 229920001425 Diethylaminoethyl cellulose Polymers 0.000 claims description 10
- JVIPLYCGEZUBIO-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3-dioxoisoindole-5-carboxylic acid Chemical compound O=C1C2=CC(C(=O)O)=CC=C2C(=O)N1C1=CC=C(F)C=C1 JVIPLYCGEZUBIO-UHFFFAOYSA-N 0.000 claims description 8
- -1 sulfoethyl Chemical group 0.000 claims description 8
- 108010015133 Galactose oxidase Proteins 0.000 claims description 7
- 108010015776 Glucose oxidase Proteins 0.000 claims description 7
- 239000004366 Glucose oxidase Substances 0.000 claims description 7
- 239000000872 buffer Substances 0.000 claims description 7
- 229940116332 glucose oxidase Drugs 0.000 claims description 7
- 235000019420 glucose oxidase Nutrition 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 102000004316 Oxidoreductases Human genes 0.000 claims description 6
- 108090000854 Oxidoreductases Proteins 0.000 claims description 6
- 230000033116 oxidation-reduction process Effects 0.000 claims description 6
- 239000011521 glass Substances 0.000 claims description 5
- 229920003023 plastic Polymers 0.000 claims description 5
- JJYPMNFTHPTTDI-UHFFFAOYSA-N 3-methylaniline Chemical compound CC1=CC=CC(N)=C1 JJYPMNFTHPTTDI-UHFFFAOYSA-N 0.000 claims description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 4
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 claims description 4
- 210000002381 plasma Anatomy 0.000 claims description 4
- 239000004033 plastic Substances 0.000 claims description 4
- 230000028327 secretion Effects 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- 239000004753 textile Substances 0.000 claims description 4
- 239000002023 wood Substances 0.000 claims description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 3
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims description 3
- 229920002873 Polyethylenimine Polymers 0.000 claims description 3
- 229920005654 Sephadex Polymers 0.000 claims description 3
- 239000012507 Sephadex™ Substances 0.000 claims description 3
- 210000001124 body fluid Anatomy 0.000 claims description 3
- 239000010839 body fluid Substances 0.000 claims description 3
- 239000003456 ion exchange resin Substances 0.000 claims description 3
- 229920003303 ion-exchange polymer Polymers 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 229940080469 phosphocellulose Drugs 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 claims description 2
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 claims description 2
- RLYCRLGLCUXUPO-UHFFFAOYSA-N 2,6-diaminotoluene Chemical compound CC1=C(N)C=CC=C1N RLYCRLGLCUXUPO-UHFFFAOYSA-N 0.000 claims description 2
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical compound C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 claims description 2
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical group C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 claims description 2
- 229940074391 gallic acid Drugs 0.000 claims description 2
- 235000004515 gallic acid Nutrition 0.000 claims description 2
- 229960001867 guaiacol Drugs 0.000 claims description 2
- 229940018564 m-phenylenediamine Drugs 0.000 claims description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 claims description 2
- 239000013060 biological fluid Substances 0.000 claims 1
- 239000002985 plastic film Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 239000003112 inhibitor Substances 0.000 description 6
- 239000008363 phosphate buffer Substances 0.000 description 6
- LTQUYHOGYCOTIT-UHFFFAOYSA-N 2-methylaniline;dihydrochloride Chemical compound Cl.Cl.CC1=CC=CC=C1N LTQUYHOGYCOTIT-UHFFFAOYSA-N 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 208000027472 Galactosemias Diseases 0.000 description 4
- 239000002738 chelating agent Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000007979 citrate buffer Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- AXNUJYHFQHQZBE-UHFFFAOYSA-N 3-methylbenzene-1,2-diamine Chemical compound CC1=CC=CC(N)=C1N AXNUJYHFQHQZBE-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000048120 Galactokinases Human genes 0.000 description 1
- 108700023157 Galactokinases Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 108010082433 UDP-glucose-hexose-1-phosphate uridylyltransferase Proteins 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- FSEUPUDHEBLWJY-HWKANZROSA-N diacetylmonoxime Chemical compound CC(=O)C(\C)=N\O FSEUPUDHEBLWJY-HWKANZROSA-N 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000005584 early death Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 208000016245 inborn errors of metabolism Diseases 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/521—Single-layer analytical elements
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP48116205A JPS5141359B2 (ja) | 1973-10-16 | 1973-10-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO742419L true NO742419L (ja) | 1975-05-12 |
Family
ID=14681428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO742419A NO742419L (ja) | 1973-10-16 | 1974-07-03 |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS5141359B2 (ja) |
| BE (1) | BE817716A (ja) |
| CA (1) | CA1025757A (ja) |
| CH (1) | CH598596A5 (ja) |
| DE (1) | DE2433426A1 (ja) |
| DK (1) | DK355674A (ja) |
| FR (1) | FR2247730B1 (ja) |
| GB (1) | GB1430512A (ja) |
| IT (1) | IT1016757B (ja) |
| NL (1) | NL7410511A (ja) |
| NO (1) | NO742419L (ja) |
| SE (1) | SE7408768L (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD143379A3 (de) * | 1978-07-25 | 1980-08-20 | Kallies Karl Heinz | Indikatorroehrchen zur glukosebestimmung |
| US4211845A (en) * | 1978-11-24 | 1980-07-08 | Miles Laboratories, Inc. | Glucose indicator and method |
| JPS60224063A (ja) * | 1984-04-20 | 1985-11-08 | Terumo Corp | 試験用具 |
| US20040219691A1 (en) * | 2003-04-29 | 2004-11-04 | Shartle Robert J. | Test strip with clear base support layer for visual perception of a liquid sample during application |
| CN101825625B (zh) * | 2009-03-06 | 2014-05-07 | 北京中生金域诊断技术有限公司 | 同时检测人体尿液中尿乳酸、肌酸和β-羟丁酸的试剂盒 |
-
1973
- 1973-10-16 JP JP48116205A patent/JPS5141359B2/ja not_active Expired
-
1974
- 1974-07-02 DK DK355674A patent/DK355674A/da not_active Application Discontinuation
- 1974-07-03 SE SE7408768A patent/SE7408768L/xx unknown
- 1974-07-03 NO NO742419A patent/NO742419L/no unknown
- 1974-07-11 DE DE2433426A patent/DE2433426A1/de not_active Withdrawn
- 1974-07-11 CA CA204,617A patent/CA1025757A/en not_active Expired
- 1974-07-12 GB GB3108074A patent/GB1430512A/en not_active Expired
- 1974-07-15 FR FR7424487A patent/FR2247730B1/fr not_active Expired
- 1974-07-16 BE BE146613A patent/BE817716A/xx unknown
- 1974-08-01 IT IT69447/74A patent/IT1016757B/it active
- 1974-08-05 NL NL7410511A patent/NL7410511A/xx not_active Application Discontinuation
- 1974-08-21 CH CH1142574A patent/CH598596A5/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK355674A (ja) | 1975-06-30 |
| DE2433426A1 (de) | 1975-04-30 |
| NL7410511A (nl) | 1975-04-18 |
| GB1430512A (en) | 1976-03-31 |
| FR2247730A1 (ja) | 1975-05-09 |
| AU7091274A (en) | 1976-01-08 |
| CH598596A5 (ja) | 1978-05-12 |
| IT1016757B (it) | 1977-06-20 |
| JPS5067188A (ja) | 1975-06-05 |
| SE7408768L (ja) | 1975-04-17 |
| JPS5141359B2 (ja) | 1976-11-09 |
| BE817716A (fr) | 1974-11-18 |
| CA1025757A (en) | 1978-02-07 |
| FR2247730B1 (ja) | 1977-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3598704A (en) | Diagnostic device for various sugars | |
| US4211845A (en) | Glucose indicator and method | |
| US2981606A (en) | Glucose indicator and method | |
| US3092465A (en) | Diagnostic test device for blood sugar | |
| FI71767C (fi) | Testkomposition och testanordning foer bestaemning av glukos i ett prov av vaetskeform samt foerfarande foer semikvantitativ bestaemning av glukos i urin. | |
| KR101821002B1 (ko) | 양호한 건강의 바이오마커를 검출하기 위한 질 표시기 | |
| JPH1031023A (ja) | 血液グルコースの測定のための試薬試験ストリツプ | |
| JPH1031024A (ja) | 血液グルコース測定のための試薬試験ストリツプ | |
| JP3491863B2 (ja) | 直読式試薬検査ストリツプのための化学タイマー | |
| KR19980024291A (ko) | 육안 시험 스트립용 화학적 타이머 | |
| JPH0317479B2 (ja) | ||
| JPH04237500A (ja) | ケトン体の検定のための組成物及び方法 | |
| US4673654A (en) | Composition for determining peroxidase-like activity of hemoglobin | |
| JPS61122568A (ja) | 水性試験試料中に含まれる高濃度領域のグルコースを半定量的に測定するための試験組成物、試験具および試験具の作製方法 | |
| JPH0550275B2 (ja) | ||
| EP0036563B1 (en) | Bilirubin-resistant composition for the determination of cholesterol, test device containing the composition and method of making the test device | |
| CA2080175A1 (en) | Copper oxidation protein assay | |
| US4251222A (en) | Sensitizers for peroxidative activity tests | |
| AU754237B2 (en) | Uric acid assay device with stabilized uricase reagent composition | |
| NO742419L (ja) | ||
| US4215995A (en) | Test means and assay for determining the urea content of fluids | |
| EP0137521B1 (en) | Integral multilayer element for chemical analysis | |
| GB2049180A (en) | Bilirubin-resistant determination of uric acid | |
| US3362886A (en) | Composition and method for the detection of galactose | |
| US3778384A (en) | Diagnostic composition for the quantitative determination of glucose |